WO2016009401A3 - Preparation of tedizolid phosphate - Google Patents
Preparation of tedizolid phosphate Download PDFInfo
- Publication number
- WO2016009401A3 WO2016009401A3 PCT/IB2015/055428 IB2015055428W WO2016009401A3 WO 2016009401 A3 WO2016009401 A3 WO 2016009401A3 IB 2015055428 W IB2015055428 W IB 2015055428W WO 2016009401 A3 WO2016009401 A3 WO 2016009401A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- tedizolid phosphate
- tedizolid
- phosphate
- processes
- Prior art date
Links
- QCGUSIANLFXSGE-GFCCVEGCSA-N tedizolid phosphate Chemical compound CN1N=NC(C=2N=CC(=CC=2)C=2C(=CC(=CC=2)N2C(O[C@@H](COP(O)(O)=O)C2)=O)F)=N1 QCGUSIANLFXSGE-GFCCVEGCSA-N 0.000 title abstract 2
- 229960003947 tedizolid phosphate Drugs 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present application relates to processes for the preparation of tedizolid phosphate.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3551CH2014 | 2014-07-18 | ||
IN3551/CHE/2014 | 2014-07-18 | ||
IN2166CH2015 | 2015-04-28 | ||
IN2166/CHE/2015 | 2015-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016009401A2 WO2016009401A2 (en) | 2016-01-21 |
WO2016009401A3 true WO2016009401A3 (en) | 2016-03-17 |
Family
ID=55079133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2015/055428 WO2016009401A2 (en) | 2014-07-18 | 2015-07-17 | Preparation of tedizolid phosphate |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016009401A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106855548B (en) * | 2016-12-21 | 2019-10-25 | 天津红日药业股份有限公司 | A kind of phosphoric acid safe ground azoles amine Related substance method |
CN107121503B (en) * | 2017-03-14 | 2020-04-28 | 南京优科制药有限公司 | Method for analyzing tedizolid phosphate and related substances thereof |
CN107382995A (en) * | 2017-09-01 | 2017-11-24 | 杭州新博思生物医药有限公司 | One pot process safe ground azoles amine |
CN110669072B (en) * | 2019-09-11 | 2022-04-19 | 天方药业有限公司 | Method for refining tedizolid phosphate |
IL299155A (en) | 2020-06-18 | 2023-02-01 | Akagera Medicines Inc | Oxazolidinone compounds, liposome preparations containing oxazolidinone compounds and methods of using them |
CN111995616A (en) * | 2020-09-22 | 2020-11-27 | 宜宾市南溪区红光制药有限公司 | Tedizolid phosphate impurity and preparation method and application thereof |
CN112961186A (en) * | 2021-02-04 | 2021-06-15 | 海南通用康力制药有限公司 | Method for purifying tedizolid phosphate |
CN115792047B (en) * | 2023-02-10 | 2023-05-19 | 四川美域高生物医药科技有限公司 | Method for detecting related substances of tedizolid phosphate intermediate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005058886A1 (en) * | 2003-12-18 | 2005-06-30 | Dong-A Pharm.Co.,Ltd. | Novel oxazolidinone derivatives |
WO2010042887A2 (en) * | 2008-10-10 | 2010-04-15 | Trius Therapeutics | Methods for preparing oxazolidinones and compositions containing them |
US20100227839A1 (en) * | 2009-02-03 | 2010-09-09 | Trius Therapeutics | Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
-
2015
- 2015-07-17 WO PCT/IB2015/055428 patent/WO2016009401A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005058886A1 (en) * | 2003-12-18 | 2005-06-30 | Dong-A Pharm.Co.,Ltd. | Novel oxazolidinone derivatives |
WO2010042887A2 (en) * | 2008-10-10 | 2010-04-15 | Trius Therapeutics | Methods for preparing oxazolidinones and compositions containing them |
US20100227839A1 (en) * | 2009-02-03 | 2010-09-09 | Trius Therapeutics | Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
Also Published As
Publication number | Publication date |
---|---|
WO2016009401A2 (en) | 2016-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016149710A3 (en) | Hiv-1 neutralizing antibodies and uses thereof | |
WO2016011222A3 (en) | Circular polynucleotides | |
WO2016079696A3 (en) | Conductive polymer coatings for three dimensional substrates | |
EP3204433B8 (en) | Process for the preparation of an alpha-nucleated polypropylene | |
WO2016061389A3 (en) | Anti-alpha-synuclein antibodies and methods of use | |
WO2016009401A3 (en) | Preparation of tedizolid phosphate | |
EP3160921A4 (en) | Process for the preparation of humic extracts from fossil sources | |
EP3166931A4 (en) | An improved process for the preparation of enzalutamide | |
WO2015191945A3 (en) | Solid state forms of sofosbuvir | |
ZA201706795B (en) | Process for the preparation of dicycloplatin | |
EP3166927A4 (en) | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids | |
EP3694499A4 (en) | Novel process for the preparation of lifitegrast | |
WO2016079110A3 (en) | Use of enzyme for cleaning | |
WO2015092810A3 (en) | Amorphous form of idelalisib | |
WO2016108206A3 (en) | Processes for preparation of idelalisib and intermediates thereof | |
EP3222624A4 (en) | Imidic acid compound having divalent anion and process for producing the same | |
EP3532055A4 (en) | Compositions and methods for the production of compounds | |
EP3405456A4 (en) | Process for the preparation of 4-alkoxy-3-acetoxypicolinic acids | |
WO2016138538A3 (en) | Therapeutic use of integrin-binding antibodies | |
EP3233814A4 (en) | Novel process for the preparation of ranolazine | |
EP3166928A4 (en) | Process for the preparation of 3-hydroxypicolinic acids | |
EP3134465A4 (en) | Improved coating compositions and processes for making the same | |
EP3016935A4 (en) | Process for the preparation of intermediate of dolutegravir | |
EP3706740A4 (en) | Processes to produce acalabrutinib | |
EP3422855A4 (en) | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15822071 Country of ref document: EP Kind code of ref document: A2 |